Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01348
http://purl.obolibrary.org/obo/dinto_DB01348
|
|---|---|
| Preferred Name | spirapril |
| Synonyms |
C22H30N2O5S2
(8S)-7-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | spirapril
|
|---|---|
| label | spirapril
|
| ATCCode | C09AA11
|
| Definition | Spirapril is an ACE inhibitor antihypertensive drug used to treat hypertension. Like many ACE inhibitors, this is a prodrug which is converted to the active metabolite spiraprilat following oral administration. ACE inhibitors are used primarily in treatment of hypertension and congestive heart failure.
|
| has pharmacological target | |
| inhibits | |
| type | |
| InChIKey | InChIKey=HRWCVUIFMSZDJS-SZMVWBNQSA-N
|
| Synonym | C22H30N2O5S2
(8S)-7-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid
|
| xref |
Wikipedia:http://en.wikipedia.org/wiki/Spirapril
PubChem Compound:5311447
PubChem Substance:46506126
ChemSpider:4470933
BindingDB:50017124
PharmGKB:PA164776913
See more
See less
|
| CASRN | 83647-97-6
|
| prefixIRI | obo2:dinto_DB01348
|
| is transported by | |
| SMILES | CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2
|
| may interact with | |
| InChI | InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1
|
| DBBrand | renormax
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |